WAM
FOLD

Wolverine Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Wolverine Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-8,400
Closed -$126K – 1496
2017
Q3 		$126K Hold
8,400
– – ﹤0.01% 1063
2017
Q2 		$84K Buy
+8,400
New +$67.6K ﹤0.01% 1058

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Wolverine Asset Management's FOLD Position: Q2 2026 in Review

Wolverine Asset Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 125,265 shares — an estimated $1.81M sold.

Wolverine Asset Management first reported a position in FOLD in Q4 2013 and held it in 6 quarters. The position peaked at $1.81M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Wolverine Asset Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Wolverine Asset Management sold 125,265 Amicus Therapeutics shares in Q2 2026, an estimated $1.81M.
  • Wolverine Asset Management first reported a position in Amicus Therapeutics in Q4 2013 and held it in 6 quarters.
  • Wolverine Asset Management's Amicus Therapeutics position peaked at $1.81M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.